EUVIMEDEUVIMED entdecken
Crossref

Should Grade Group 1 (GG1) be called cancer?

Craig V Labbate, Gladell P Paner, Scott E Eggener

World Journal of Urology · 2022-01 · 40 (1) · 15-19

DOI: 10.1007/s00345-020-03583-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, online erschienen am 11.01.2021. Verfasst von Craig V Labbate und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Urology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Terminology as Topic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: ISUP Grade Group 1 prostate cancer is the lowest histologic grade of prostate cancer with a clinically indolent course. Removal of the term 'cancer' has been proposed and has historical precedent both in urothelial and thyroid carcinoma. METHODS: Evidence-based review identifying arguments for and against Grade Group 1 being referred to as cancer. RESULTS: Grade Group 1 has histologic evidence of tissue microinvasion and 0.3-3% rate of extraprostatic extension. Genomic evaluation suggests overlap of a minority of Grade Group 1 cancers with those of Grade Group 2. Conversely, Grade Group 1 tumors appear to have distinct genetic and genomic profiles from Grade Group 3 or higher tumors. Grade Group 1 has no documented ability for regional or distant metastasis and long-term follow up after treatment or active surveillance is safe with excellent oncologic outcomes. DISCUSSION: Grade Group 1 prostate cancer, while showing evidence of neoplasia on histology has a remarkably indolent natural history more akin to non-neoplastic precursor lesions. Consideration should be given to renaming Grade Group 1 prostate cancer, which has the potential to minimize overtreatment, treatment-related side effects, patient anxiety, and financial burden on the healthcare system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Terminology as TopicHumansMaleNeoplasm GradingProstatic Neoplasms

Stichwörter der Autor:innen

Active surveillanceGleason GradingProstate cancer

Autor:innen und Institutionen

  • Section of Urology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA.
  • Department of Pathology, University of Chicago Medicine, Chicago, IL, USA.
  • Section of Urology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. seggener@surgery.bsd.uchicago.edu.

Zitieren

APA

Labbate, C. V., Paner, G. P., & Eggener, S. E. (2022). Should Grade Group 1 (GG1) be called cancer?. World Journal of Urology, 40(1), 15-19. https://doi.org/10.1007/s00345-020-03583-4

Vancouver

Labbate CV, Paner GP, Eggener SE. Should Grade Group 1 (GG1) be called cancer?. World Journal of Urology. 2022;40(1):15-19. doi:10.1007/s00345-020-03583-4

BibTeX
@article{Labbate2022,
  author = {Labbate, Craig V and Paner, Gladell P and Eggener, Scott E},
  title = {Should Grade Group 1 (GG1) be called cancer?},
  journal = {World Journal of Urology},
  year = {2022},
  volume = {40},
  number = {1},
  pages = {15--19},
  doi = {10.1007/s00345-020-03583-4}
}
Kostenlos starten →